CA1003332A - Process for isolating a fibrin-stabilizing factor from human placenta extracts - Google Patents

Process for isolating a fibrin-stabilizing factor from human placenta extracts

Info

Publication number
CA1003332A
CA1003332A CA130,487A CA130487A CA1003332A CA 1003332 A CA1003332 A CA 1003332A CA 130487 A CA130487 A CA 130487A CA 1003332 A CA1003332 A CA 1003332A
Authority
CA
Canada
Prior art keywords
fibrin
isolating
human placenta
stabilizing factor
placenta extracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA130,487A
Other languages
English (en)
Other versions
CA130487S (en
Inventor
Hans Bohn
Fritz Emmerich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of CA1003332A publication Critical patent/CA1003332A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA130,487A 1970-12-22 1971-12-20 Process for isolating a fibrin-stabilizing factor from human placenta extracts Expired CA1003332A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2063069A DE2063069C3 (de) 1970-12-22 1970-12-22 Verfahren zur Herstellung eines Arzneimittels mit fibrinstabilisierender Wirkung

Publications (1)

Publication Number Publication Date
CA1003332A true CA1003332A (en) 1977-01-11

Family

ID=5791792

Family Applications (1)

Application Number Title Priority Date Filing Date
CA130,487A Expired CA1003332A (en) 1970-12-22 1971-12-20 Process for isolating a fibrin-stabilizing factor from human placenta extracts

Country Status (14)

Country Link
JP (1) JPS5320566B1 (xx)
AT (1) AT310940B (xx)
BE (1) BE777135A (xx)
BR (1) BR7108491D0 (xx)
CA (1) CA1003332A (xx)
CH (1) CH575236A5 (xx)
DE (1) DE2063069C3 (xx)
DK (1) DK129386B (xx)
ES (1) ES398015A1 (xx)
FR (1) FR2119008B1 (xx)
GB (1) GB1380270A (xx)
IL (1) IL38402A (xx)
NL (1) NL159583B (xx)
SE (1) SE388774B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2600078B1 (fr) * 1986-06-12 1989-07-13 Merieux Inst Procede de preparation de facteur xiii a partir du placenta
WO1991000098A1 (en) * 1989-06-23 1991-01-10 Kishinevsky Selskokhozyaistvenny Institut Imeni M.V.Frunze Anti-inflammatory preparation and method of obtaining it
CN111000253A (zh) * 2019-12-03 2020-04-14 武汉跃莱健康产业有限公司 复合多肽蛋白质粉及其制备方法

Also Published As

Publication number Publication date
SE388774B (sv) 1976-10-18
DK129386C (xx) 1975-02-24
IL38402A0 (en) 1972-02-29
JPS5320566B1 (xx) 1978-06-27
FR2119008A1 (xx) 1972-08-04
DE2063069C3 (de) 1975-05-07
AT310940B (de) 1973-10-25
BR7108491D0 (pt) 1973-05-08
NL159583B (nl) 1979-03-15
IL38402A (en) 1975-04-25
AU3708771A (en) 1973-05-24
BE777135A (fr) 1972-06-22
ES398015A1 (es) 1974-07-01
FR2119008B1 (xx) 1975-03-14
DE2063069B2 (de) 1974-09-05
NL7117364A (xx) 1972-06-26
DE2063069A1 (de) 1972-06-29
DK129386B (da) 1974-10-07
CH575236A5 (xx) 1976-05-14
GB1380270A (en) 1975-01-08

Similar Documents

Publication Publication Date Title
CA957802A (en) Vascular prosthetic
CA1008849A (en) Ap-glycoproteins and process for isolating them
AU459934B2 (en) Multi-circuit moldule and method for making
CA957943A (en) Process for isolating a fibrin-stabilizing factor from human placenta extracts
CA1003332A (en) Process for isolating a fibrin-stabilizing factor from human placenta extracts
CA933288A (en) Method of operating piezoelectric transformers
AU472664B2 (en) Methods for the fractionation of amyloses
CA963808A (en) Perspiration-responsive aerosol deodorant
AU435492B2 (en) Process for isolating a fibrin-stabilizing factor
AU5850169A (en) Method of covering
CA978908A (en) Aerosol valve
CA858316A (en) Aerosol filter
CA837836A (en) Language aid system
CA835418A (en) Cycloaliphatic alkylhydroxyphenylalkanoates
CA960220A (en) Cycloalkyl p-aminobenzoates
CA902645A (en) Process for the isolation of d-isothujone
CA835196A (en) Aerosol valve unit
CA898692A (en) Process for the isolation of calcitonin
CA787897A (en) Method of making peptides
CA854652A (en) Soil-treating procedure
AU445995B2 (en) Isolating switch
CA777183A (en) Method for the preparation of arylisothiocyanates
CA776702A (en) Method for the preparation of arylisothiocyanates
CA861487A (en) Fractionation system
AU449530B2 (en) Anticoagulant isolation